Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

No More 'Hidden' Facilities, US FDA Tells Generic Sponsors

Executive Summary

Agency officials don't care if DMF holder doesn't give access to its entire facility list; FDA says industry is responsible for listing all facilities that could be used as part of ANDA.

You may also be interested in...



Missed ANDA Nods Mostly Due To 'Imminent Approval'

US FDA will miss goal dates to reach speedier generic drug application approvals, but says decisions will be case by case.

ANDA User Fee Misses Are Mostly Part Of 'Imminent Approval' Process

US FDA will miss goal dates to reach speedier generic drug application approvals, but says decisions will be case by case.

ANDA Sponsors Urged To Ask DMF Holders About 'Hidden Facilities'

FDA says 16% of ANDAs have an issue with "hidden facilities" that are listed in drug master files but not the ANDAs they are linked with; industry official offers some tips to bridge this communications gap with DMF holders.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS122020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel